MedPath

TobraDex

TobraDex

Approved
Approval ID

fe08bcd5-4d14-4c2d-940c-b7968f9a89f0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 27, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

tobramycin and dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-628
Application NumberNDA050616
Product Classification
M
Marketing Category
C73594
G
Generic Name
tobramycin and dexamethasone
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateNovember 20, 2006
FDA Product Classification

INGREDIENTS (5)

tobramycinActive
Quantity: 3 mg in 1 g
Code: VZ8RRZ51VK
Classification: ACTIB
chlorobutanolInactive
Quantity: 5 mg in 1 g
Code: HM4YQM8WRC
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
dexamethasoneActive
Quantity: 1 mg in 1 g
Code: 7S5I7G3JQL
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TobraDex - FDA Drug Approval Details